/
SER
$2.85+$0.03 (+1.06%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$42.3M
15M shares
52-week range
$1.22 – $7.92
24% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
XASE
CS
Change$-12.02
Serina Therapeutics, Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.
www.serinatherapeutics.com- Employees
- 16
- IPO / List date
- Mar 27, 2024
- HQ
- HUNTSVILLE, AL
Held by traders on TradeandTell
No one on the platform currently holds SER.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in SER as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded SER yet.
